细胞疗法对盆腔神经血管损伤大鼠模型勃起功能改善的长期疗效
研究在大鼠双侧神经血管损伤性勃起功能障碍(NVED)模型中,比较三种人细胞类型海绵体内注射后12周的勃起功能与组织学效果。结果显示细胞治疗组海绵体内压与平均动脉压比值显著高于生理盐水对照组(P < 0.05),且阴茎组织中内皮、平滑肌和神经细胞标志物表达细胞更多。提示细胞疗法可能改善NVED的长期组织再生与功能结局。
要点
- 三种人细胞海绵体内注射均显著改善NVED大鼠勃起功能指标(P < 0.05)。
- 细胞治疗组阴茎组织内皮、平滑肌及神经标志物表达细胞多于对照。
- 12周随访提示细胞疗法可能促进神经、肌源及血管组织长期再生。
核心结论
- 细胞疗法在盆腔神经血管损伤后12周增强大鼠勃起功能并改善阴茎组织学改变。
- 细胞疗法可能改善NVED治疗中神经、肌源及血管组织再生的长期结局。
研究设计与样本
- 在无胸腺大鼠中建立双侧海绵体神经挤压及双侧阴部内神经血管束结扎的双重NVED模型。
- 造模时海绵体内注射三种人细胞(2.5 × 106 cells/0.2 mL:脐静脉内皮细胞、脂肪来源干细胞、羊水来源干细胞),生理盐水0.2 mL为对照。
- 造模及注射后12周评估勃起功能与阴茎组织组织形态学分析。
主要发现
- 细胞治疗组海绵体内压与平均动脉压比值显著高于生理盐水对照组(P < 0.05)。
- 免疫荧光染色显示细胞治疗组阴茎组织内内皮、平滑肌和神经细胞标志物表达细胞多于对照组。
临床怎么用
- 为NVED细胞疗法长期疗效提供临床前证据,支持进一步开展转化研究。
- 提示海绵体内细胞注射可能同时靶向神经、肌源及血管组织再生。
局限性
- 研究为大鼠模型,结果不能直接外推至人类。
- 样本量、具体P值及置信区间未在摘要中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the long-term therapeutic effect amongst three human cell types on erectile function recovery in a rat model of dual neurovascular-injury erectile dysfunction (NVED). MATERIALS AND METHODS: A dual NVED model was established in athymic rats by crushing the bilateral cavernous nerves and ligating the bilateral internal pudendal neurovascular bundles. At the time of defect creation, three different types of human cell populations (2.5 × 106 cells/0.2 mL: umbilical vein endothelial cells, adipose-derived stem cells, and amniotic fluid-derived stem cells) were injected intracavernously into the penile tissue. Saline injection (0.2 mL) served as a control group. Erectile function and histomorphological analyses of penile tissues were assessed 12 weeks after defect creation and cell or saline injection. RESULTS: The ratio of intracavernous pressure to mean arterial pressure (functional indicator) was significantly higher in the cell therapy groups compared to the saline-injected control group (P < 0.05). Immunofluorescence staining showed more cells expressing biomarkers of endothelial, smooth muscle, and nerve cells within the penile tissue in the cell therapy groups when compared to the control group. CONCLUSIONS: Cell therapy enhanced erectile function and ameliorated the histological changes 12 weeks after pelvic neurovascular injury in vivo, indicating that cell therapy may improve the long-term outcomes in neurogenic, myogenic and vascular tissue regeneration in the treatment of NVED.
引用
- Gu X, Shi H, Matz E, et al. Long-term therapeutic effect of cell therapy on improvement in erectile function in a rat model with pelvic neurovascular injury. BJU Int. 2019. PMID: 30499626. doi:10.1111/bju.14631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。